| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Danaher Corp /de/ (DHR) has 21 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. DHR is classified in the Life Sciences Tools & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 3.11M | $545.57M | - | |
| Dir | 30.8K | $5.41M | - | |
| CFO | 20.1K | $3.52M | - | |
| Dir | 19.8K | $3.48M | - | |
| CEO | 19.7K | $3.46M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 21, 2023 | Gutierrez-Ramos Jose-Carlos | SVP, Chief Science Officer | Sell | 590 | $250.54 | $147,818.60 | -7.8% | -15.6% | +8.6% | |
| Jul 28, 2023 | Filler Linda58 | Director | Sale+OE | 10,190 | $260.25 | $2,651,978.32 | -11.8% | -25.5% | +5.3% | |
| Jul 28, 2023 | Raskas Daniel67 | SVP - Corporate Development | Sale+OE | 11,213 | $260.65 | $2,922,651.63 | -22.7% | -25.5% | +5.3% | |
| Jul 26, 2023 | Weidemanis Joakim67 | Executive Vice President | Sale+OE | 22,439 | $263.42 | $5,910,832.01 | -20.2% | -25.7% | +2.0% | |
| Jul 26, 2023 | List Teri55 | Director | Sale+OE | 3,490 | $263.30 | $918,917.00 | -16.6% | -25.7% | +2.0% | |
| May 31, 2023 | Raskas Daniel67 | SVP - Corporate Development | Sale+OE | 19,847 | $228.50 | $4,535,039.50 | -33.9% | +15.0% | +10.1% | |
| May 5, 2023 | Lohr Walter G51 | - | Sale+OE | 3,490 | $240.88 | $840,685.16 | -22.4% | +6.2% | +2.5% | |
| May 4, 2023 | Couchara Georgeann56 | SVP, Human Resources | Sell | 695 | $245.27 | $170,462.65 | -30.8% | +6.4% | +2.5% | |
| May 4, 2023 | Weidemanis Joakim67 | Executive Vice President | Sale+OE | 9,934 | $245.27 | $2,436,512.18 | -9.8% | +6.4% | +2.5% | |
| May 1, 2023 | Gutierrez-Ramos Jose-Carlos | SVP, Chief Science Officer | Sell | 500 | $242.19 | $121,096.40 | -6.2% | +5.5% | +2.0% |